Search

Jason A. Deck

Examiner (ID: 427)

Most Active Art Unit
1627
Art Unit(s)
1627
Total Applications
619
Issued Applications
298
Pending Applications
2
Abandoned Applications
319

Applications

Application numberTitle of the applicationFiling DateStatus
13/992137 PHARMACEUTICAL COMPOSITION COMPRISING TRANS-CINNAMALDEHYDE AND ITS USE IN THE TREATMENT OF INFECTIONS Aug 20, 2013 Abandoned
Array ( [id] => 9198815 [patent_doc_number] => 20130338130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS' [patent_app_type] => utility [patent_app_number] => 13/970524 [patent_app_country] => US [patent_app_date] => 2013-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38167 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970524 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/970524
METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS Aug 18, 2013 Abandoned
Array ( [id] => 10346087 [patent_doc_number] => 20150231092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'NOVEL EFFERVESCENT SACHET FORMULATIONS OF DAPOXETINE AND A PDE5 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/421333 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3886 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421333 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/421333
NOVEL EFFERVESCENT SACHET FORMULATIONS OF DAPOXETINE AND A PDE5 INHIBITOR Aug 14, 2013 Abandoned
Array ( [id] => 12044547 [patent_doc_number] => 09822139 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'Pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment' [patent_app_type] => utility [patent_app_number] => 13/960986 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13655 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960986 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/960986
Pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment Aug 6, 2013 Issued
Array ( [id] => 9149053 [patent_doc_number] => 20130303576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'ENZYME INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/946488 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18120 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946488 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/946488
ENZYME INHIBITORS Jul 18, 2013 Abandoned
Array ( [id] => 11778158 [patent_doc_number] => 09387193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof' [patent_app_type] => utility [patent_app_number] => 13/944634 [patent_app_country] => US [patent_app_date] => 2013-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10509 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944634 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/944634
Composition comprising scirpusin A and scirpusin B and anti-adipogenesis/anti-obesity potential thereof Jul 16, 2013 Issued
Array ( [id] => 12111400 [patent_doc_number] => 09867373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Fungicidal composition having synergistic effect' [patent_app_type] => utility [patent_app_number] => 14/889924 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13252 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14889924 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/889924
Fungicidal composition having synergistic effect Jun 12, 2013 Issued
13/906155 Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate May 29, 2013 Abandoned
Array ( [id] => 9042479 [patent_doc_number] => 20130245117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'NOVEL USE OF CAPSIATE OR DIHYDROCAPSIDATE' [patent_app_type] => utility [patent_app_number] => 13/889808 [patent_app_country] => US [patent_app_date] => 2013-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14130 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889808 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/889808
Use of capsiate or dihydrocapsidate May 7, 2013 Issued
Array ( [id] => 10920424 [patent_doc_number] => 20140323444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'ANTI-INFLAMMATORY AND ANTIDIABETIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/869117 [patent_app_country] => US [patent_app_date] => 2013-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869117 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/869117
ANTI-INFLAMMATORY AND ANTIDIABETIC AGENTS Apr 23, 2013 Abandoned
Array ( [id] => 9095020 [patent_doc_number] => 20130274331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'Method for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and an Anti-Inflammatory Agent' [patent_app_type] => utility [patent_app_number] => 13/862262 [patent_app_country] => US [patent_app_date] => 2013-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13016 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13862262 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/862262
Method for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and an Anti-Inflammatory Agent Apr 11, 2013 Abandoned
Array ( [id] => 15911845 [patent_doc_number] => 10653137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-19 [patent_title] => Arthropod pest control composition and method [patent_app_type] => utility [patent_app_number] => 13/858281 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4229 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858281 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/858281
Arthropod pest control composition and method Apr 7, 2013 Issued
Array ( [id] => 9739326 [patent_doc_number] => 20140275045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/838372 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24085 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838372 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/838372
PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS Mar 14, 2013 Abandoned
Array ( [id] => 9436024 [patent_doc_number] => 20140113931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'SUBSTITUTED PICOLINAMIDE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/841867 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21282 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841867 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/841867
SUBSTITUTED PICOLINAMIDE KINASE INHIBITORS Mar 14, 2013 Abandoned
Array ( [id] => 9739241 [patent_doc_number] => 20140274961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'Compounds and uses thereof for the modulation of hemoglobin' [patent_app_type] => utility [patent_app_number] => 13/815810 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8684 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815810 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/815810
Compounds and uses thereof for the modulation of hemoglobin Mar 14, 2013 Abandoned
Array ( [id] => 9739462 [patent_doc_number] => 20140275181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'Compounds and uses thereof for the modulation of hemoglobin' [patent_app_type] => utility [patent_app_number] => 13/815874 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10145 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815874 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/815874
Compounds and uses thereof for the modulation of hemoglobin Mar 14, 2013 Issued
Array ( [id] => 9081972 [patent_doc_number] => 20130267502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/835607 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 79459 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835607 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/835607
Treatment of addiction and impulse-control disorders using PDE7 inhibitors Mar 14, 2013 Issued
Array ( [id] => 12036517 [patent_doc_number] => 09814729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'Nerve agent antidotes' [patent_app_type] => utility [patent_app_number] => 13/830615 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13321 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830615 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/830615
Nerve agent antidotes Mar 13, 2013 Issued
Array ( [id] => 9122355 [patent_doc_number] => 20130289277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'MEDICAMENT FOR TREATING MENTAL AND BEHAVIOURAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/827655 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6925 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13827655 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/827655
Medicament for treating mental and behavioural disorders Mar 13, 2013 Issued
Array ( [id] => 9397050 [patent_doc_number] => 20140094456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'ANTI-FIBROTIC PYRIDINONES' [patent_app_type] => utility [patent_app_number] => 13/799727 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97666 [patent_no_of_claims] => 165 [patent_no_of_ind_claims] => 95 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13799727 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/799727
ANTI-FIBROTIC PYRIDINONES Mar 12, 2013
Menu